28109. Panelist
Session: Interactive Symposium: Challenging Cases in Clinical Infectious Diseases
Sunday, October 26, 2008: 12:00 AM
Room: Ballroom B
Kami Kim, MD, Albert Einstein College of Medicine, Bronx, NY and  K. Kim, MD, None.

Kami Kim, MD
Harvard University, Cambridge, MA A.B. 1980
Columbia Coll. of Physicans & Surgeons, NY, NY M.D. 1984
1984-1987 Intern/Resident, Medical Service, Columbia-Presbyterian Medical Center, New York, NY
1987-1988 Clinical Fellow, Division of Infectious Diseases, University of California, San Francisco
1988-1990 Postdoctoral Fellow, Parasitology Laboratory, James Leech, M.D. and Richard Nelson, Ph.D., San Francisco General Hospital, UCSF.
1988-1994 Attending Physician, San Francisco County Tuberculosis Clinic, SF, CA
1990-1994 Postdoctoral Fellow, Department Microbiology & Immunology, John Boothroyd, Ph.D., Stanford University School of Medicine, Stanford, CA.
1995-2002 Assistant Professor of Medicine and of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY
2002-2007 Associate Professor of Medicine and of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY
2007-present Professor of Medicine and of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY
Honors and Awards:
Magna Cum Laude, Harvard University (1980); Bank of America-Giannini Foundation Fellowship for Medical Research (1988-1989); National Research Service Award (F32; NIH-NIAID; 1989-1992); University of California University-wide AIDS Research Program Fellowship (1992-1993); Clinical Investigator Award (KO8; NIH-NIAID; 1993-1996); NIH First Award (R29; NIAID; 1997-2002) ; NIH Independent Scientist Award (KO2; NIH-NIAID; 1998-2003); Burroughs Wellcome Fund, New Investigator Award in Molecular Parasitology (1998-2002); Burroughs Wellcome Fund, New Initiatives in Malaria Research (2001-2003); American Society for Clinical Investigation (2004), Fellow, Infectious Diseases Society of America (2006)
Selected peer-reviewed publications
Kirkman, L.A., L.M. Weiss, K.Kim. Cyclic nucleotide signalling in Toxoplasma gondii bradyzoite differentiation. Infect.Immun. 69:148-153. 2001.
Miller, S. A., E.M. Binder, M. J. Blackman, V. B. Carruthers, K. Kim. A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. J. Biol. Chem. 276: 45341-45348, 2001.
Kicska,G.A., P.C. Tyler, G.B. Evans, R.H. Furneaux, V.L. Schramm, K.Kim. Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase. J. Biol. Chem. 277: 3226-3231. 2002.
Kicska,G.A., P.C. Tyler, G.B. Evans, R.H. Furneaux, K.Kim, V.L. Schramm. Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum. J. Biol. Chem. 277: 3219-3225. 2002.
Khan, F., J. Tang, C. Qin, K. Kim. Cyclin dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii. Mol. Microbiol. 45:321-32. 2002.
Miller, S.A., V. Thathy, J.W. Ajioka, M.J. Blackman, K. Kim. TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Mol Microbiol 49:883-94. 2003
Kicska, G.A., L. M. Ting, V. L. Schramm, K. Kim. Impact of dietary PABA on murine Plasmodium yoelii infection. J. Inf. Dis. 188:1776-81. 2003
Shi, W, L.M. Ting, A. Lewandowicz, P.C. Tyler, G.B. Evans, R.H. Furneaux, K. Kim, S.C. Almo, and V.L. Schramm Plasmodium falciparum purine nucleoside phosphorylase: Crystal structures, immucillin inhibitors and dual catalytic function. Accelerated communication. J Biol Chem. 279:18103-6. 2004.
Ting L-M, W. Shi, A. Lewandowicz, V. Singh, A. Mwakingwe, MR Birck, EA Taylor Ringia, G. Bench, DC Madrid, PC Tyler, GB Evans, RH Furneaux, VL Schramm, K Kim. Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. J Biol Chem 280:9547-54. 2005.
Howell, SJ, F.Hackett, AM Jongco, C. Withers Martinez, <